BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 37183167)

  • 1. Prophylactic mastectomy and bilateral salpingo-oophorectomy in patients with breast cancer: a systematic review of postsurgical sexual function and menopausal hormone therapy symptom mitigation.
    Morgan O; Belda R; Schnur J; Montgomery G; Parmar S; Chirivella I; Cano A
    Sex Med Rev; 2023 Dec; 12(1):3-13. PubMed ID: 37183167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Satisfaction and overall quality of life in BRCA positive women after prophylactic surgeries].
    Šašková P; Pavlišta D; Dostálek L
    Rozhl Chir; 2017; 96(8):328-333. PubMed ID: 29058922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bilateral prophylactic mastectomy in BRCA mutation carriers: what surgeons need to know.
    Franceschini G; Di Leone A; Terribile D; Sanchez MA; Masetti R
    Ann Ital Chir; 2019; 90():1-2. PubMed ID: 30872561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of bilateral salpingo-oophorectomy on menopausal symptoms and sexual functioning among women with a BRCA1 or BRCA2 mutation.
    Hall E; Finch A; Jacobson M; Rosen B; Metcalfe K; Sun P; Narod SA; Kotsopoulos J
    Gynecol Oncol; 2019 Jan; 152(1):145-150. PubMed ID: 30414741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quality of life after risk-reducing surgery for breast and ovarian cancer prevention: a systematic review and meta-analysis.
    Wei X; Oxley S; Sideris M; Kalra A; Brentnall A; Sun L; Yang L; Legood R; Manchanda R
    Am J Obstet Gynecol; 2023 Oct; 229(4):388-409.e4. PubMed ID: 37059410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surgical decision making in premenopausal
    Gaba F; Goyal S; Marks D; Chandrasekaran D; Evans O; Robbani S; Tyson C; Legood R; Saridogan E; McCluggage WG; Hanson H; Singh N; Evans DG; Menon U; Manchanda R;
    J Med Genet; 2022 Feb; 59(2):122-132. PubMed ID: 33568437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prophylactic salpingectomy and delayed oophorectomy as an alternative for BRCA mutation carriers.
    Kwon JS; Tinker A; Pansegrau G; McAlpine J; Housty M; McCullum M; Gilks CB
    Obstet Gynecol; 2013 Jan; 121(1):14-24. PubMed ID: 23232752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk-Reducing Bilateral Salpingo-Oophorectomy for BRCA Mutation Carriers and Hormonal Replacement Therapy: If It Should Rain, Better a Drizzle than a Storm.
    Gasparri ML; Taghavi K; Fiacco E; Zuber V; Di Micco R; Gazzetta G; Valentini A; Mueller MD; Papadia A; Gentilini OD
    Medicina (Kaunas); 2019 Jul; 55(8):. PubMed ID: 31362334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mindfulness-based stress reduction for menopausal symptoms after risk-reducing salpingo-oophorectomy (PURSUE study): a randomised controlled trial.
    van Driel C; de Bock GH; Schroevers MJ; Mourits MJ
    BJOG; 2019 Feb; 126(3):402-411. PubMed ID: 30222235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prophylactic mastectomy with immediate reconstruction combined with simultaneous laparoscopic salpingo-oophorectomy via a transmammary route: a novel surgical approach to female BRCA-mutation carriers.
    Perabò M; Fink V; Günthner-Biller M; von Bodungen V; Friese K; Dian D
    Arch Gynecol Obstet; 2014 Jun; 289(6):1325-30. PubMed ID: 24389920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hormone replacement therapy after risk reducing salpingo-oophorectomy in patients with BRCA1 or BRCA2 mutations; a systematic review of risks and benefits.
    Gordhandas S; Norquist BM; Pennington KP; Yung RL; Laya MB; Swisher EM
    Gynecol Oncol; 2019 Apr; 153(1):192-200. PubMed ID: 30661763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new strategy for prophylactic surgery in BRCA women: Combined mastectomy and laparoscopic salpingo-oophorectomy with immediate reconstruction by double DIEP flap.
    Hunsinger V; Marchac AC; Derder M; Hivelin M; Lecuru F; Bats AS; Lantieri L
    Ann Chir Plast Esthet; 2016 Jun; 61(3):177-82. PubMed ID: 26946931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of pre-operative menopausal status and hormone replacement therapy (HRT) on sexuality and quality of life after risk-reducing salpingo-oophorectomy.
    Tucker PE; Bulsara MK; Salfinger SG; Tan JJ; Green H; Cohen PA
    Maturitas; 2016 Mar; 85():42-8. PubMed ID: 26857878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Uptake and timing of risk-reducing salpingo-oophorectomy among patients with BRCA1 and BRCA2 mutations.
    Smith MJ; Gerber D; Olsen A; Khouri OR; Wang Y; Liu M; Smith J; Pothuri B
    Am J Obstet Gynecol; 2021 Nov; 225(5):508.e1-508.e10. PubMed ID: 34171390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Role of Hormonal Replacement Therapy in BRCA Mutated Patients: Lights and Shadows.
    Loizzi V; Dellino M; Cerbone M; Arezzo F; Cazzato G; Damiani GR; Pinto V; Silvestris E; Kardhashi A; Cicinelli E; Cascardi E; Cormio G
    Int J Mol Sci; 2023 Jan; 24(1):. PubMed ID: 36614207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interventions to improve psychosocial well-being in female BRCA-mutation carriers following risk-reducing surgery.
    Jeffers L; Reid J; Fitzsimons D; Morrison PJ; Dempster M
    Cochrane Database Syst Rev; 2019 Oct; 10(10):CD012894. PubMed ID: 31595976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of prophylactic salpingo-oophorectomy on menopausal symptoms and sexual function in women who carry a BRCA mutation.
    Finch A; Metcalfe KA; Chiang JK; Elit L; McLaughlin J; Springate C; Demsky R; Murphy J; Rosen B; Narod SA
    Gynecol Oncol; 2011 Apr; 121(1):163-8. PubMed ID: 21216453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The psychosexual effects of risk-reducing bilateral salpingo-oophorectomy in female BRCA1/2 mutation carriers: A systematic review of qualitative studies.
    Hickey I; Jha S; Wyld L
    Gynecol Oncol; 2021 Mar; 160(3):763-770. PubMed ID: 33317909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prophylactic oophorectomy in women at increased cancer risk.
    Domchek SM; Rebbeck TR
    Curr Opin Obstet Gynecol; 2007 Feb; 19(1):27-30. PubMed ID: 17218848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of risk reducing bilateral salpingo-oophorectomy on sexual function in BRCA1/2 mutation carriers and women with Lynch syndrome: A systematic review and meta-analysis.
    Kershaw V; Hickey I; Wyld L; Jha S
    Eur J Obstet Gynecol Reprod Biol; 2021 Oct; 265():7-17. PubMed ID: 34416580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.